We are the Peptide Experts

JPT Peptide Technologies is the leading manufacturer of custom peptides and innovative peptide-based products for research and clinical applications. For more than 15 years we have been serving the worldwide biomedical community with science and quality driven products and services.

Located in our state-of-the-art laboratories in Berlin, Germany, JPT operates according to the most recent ISO 9001:2015 regulations.

Custom Peptide Synthesis

Our Quality Guarantee

Since 2004 JPT maintains an active quality management system that is annually reviewed, audited and certified by an independent certifcation body (TÜV Rheinland) to meet ISO 9001 standards. Therefore, we have installed complete process documentation and an early signaling procedure in case of problems.

Product Finder

Search by scientific field

Search by keyword

Research Fields

Cell Therapy & Vaccines

JPT offers a large portfolio of peptide products and services supporting all development phases of new cell therapies and vaccines. These products range from discovery tools for epitope and target identification, to various peptide formats for immune monitoring and clinical grade peptides to support clinical vaccination and cell therapy trials. Learn more

Immunology

JPT has developed a variety of unique peptide-based products allowing systematic evaluation of cellular and humoral immunity. In addition to peptide formats allowing T-cell and B-cell epitope discovery, antigen-specific T-cell stimulation and immune monitoring our clinical grade products support clinical trials for the development of new immunotherapeutics and vaccines. Learn more

Neo-Epitope Discovery & Therapy

Neo-epitopes are important targets for individualized cancer immunotherapy. JPT’s high-throughput peptide techniques enable access to customized peptide products for neo-epitope prioritization and validation, individualized therapy development and immune monitoring. Learn more

Proteomics

Proteomics is the study of a cell's protein inventory at different times by protein identification and quantification. The application of mass spectrometry and more specifically LC-MS/MS has tremendously facilitated this process. JPT developed proprietary approaches for the provision of quantified custom peptides and ready-to-use products enabling protein biomarker identification and quantitation. Learn more

COVID-19

JPT was the first company responding to the Covid-19 pandemic with the launch of a broad SARS CoV-2 genome spanning portfolio of peptide tools. The ready to use and custom peptide tools include antigen spanning PepMixTM peptide pools and PepStarTM peptide microarrays of SARS-CoV-2 wild type and mutated antigen sequences as well as antigens from other relevant corona viruses. Learn more

News

This February: RSV Peptide Pools & Arrays 20% OFF

Entering the second month of 2023 we announce a 20% discount on all our RSV catalog PepMix Peptide Pools and PepStar Peptide Microarrays. For cellular immune response monitoring and T-cell epitope identification we want to point you in the direction of our RSV PepMix Peptide Pools. To map antibody epitopes and monitor humoral immune responses of RSV we refer you to...

Learn More

February 2023

Meet us at IO360° in New York

Learn about peptide-driven cell- and immunotherapy approaches and assays using our state-of-the-art peptide tools and services for all phases of therapy and vaccine development. We will be attending the

9th Annual Immuno-Oncology 360°
Feb 7 -10, New York, NY, USA
Meet our US Team: Aude-Marie Alem and Aaron Castro

Learn More

January 2023

INCOMING: New Peptide Peptide Pools for M. Tuberculosis

With antibiotic and drug resistant tuberculosis being on the rise, close epidemiological monitoring, drug and vaccine development, and diagnostic tests to also detect resistance are imperative in combatting its spread. The new PepMixes cover the antigens for secretion system -, secretion-associated, and extracellular immunogenic proteins:

Learn More

January 2023